Abstract
Biomarkers for diagnosis, treatment, and outcome prediction after stroke are lacking. Therefore, we aimed to evaluate the association between increased serum troponin, stroke severity, and mortality. Unselected patients with acute ischemic stroke assessed for troponin levels were included over the span of 1 year. Risk-factor profile, stroke etiology, stroke severity, and mortality during acute admission were recorded. The study included 212 patients, and 35 had increased troponin levels. Elevated troponin levels were associated with older age (82.1 ± 10.7 vs. 72.2 ± 12.6, p < 0.001), poor kidney function (calculated GFR 58.7 ± 29.8 vs. 82.7 ± 28.4, p < 0.001), and known ischemic heart disease (51.4 % vs. 33.9 %, p = 0.049). Patients with increased troponin had increased stroke severity on admission (National Institutes of Health Stroke Scale (NIHSS) 16.0 ± 9.4 vs. 10.4 ± 8.0, p < 0.001). This association remained significant after multivariate analysis but was nonlinear. Mortality rates were significantly higher in patients with increased troponin (37.1 vs. 5.6 %, p < 0.001). On multivariate analysis, elevated troponin (odds ratio [OR] 22.57, 95 % CI 4.4–116.6), absence of ischemic heart disease (OR 10.3, 95 % CI 1.8–57.6), and admission NIHSS score (OR 1.59 for every 5 points, 95 % CI 1.1–2.4) were associated with mortality. This study indicates that elevated troponin is an independent marker for severe deficits on presentation and for mortality in stroke patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke J Cereb Circ 24:35–41
Agewall S, Giannitsis E, Jernberg T, Katus H (2011) Troponin elevation in coronary vs. non-coronary disease. Eur Heart J 32:404–411
Akhter S, Zhang Z, Jin JP (2012) The heart-specific NH2-terminal extension regulates the molecular conformation and function of cardiac troponin I. Am J Physiol Heart Circ Physiol 302:H923–H933
Beaulieu-Boire I, Leblanc N, Berger L, Boulanger JM (2013) Troponin elevation predicts atrial fibrillation in patients with stroke or transient ischemic attack. J Stroke Cereb Dis Off J Natl Stroke Assoc 22:978–983
Chen C, Liu JB, Bian ZP et al (2014) Cardiac troponin I is abnormally expressed in non-small cell lung cancer tissues and human cancer cells. Int J Clin Exp Pathol 7:1314–1324
Faiz KW, Thommessen B, Einvik G, Brekke PH, Omland T, Ronning OM (2014a) Determinants of high sensitivity cardiac troponin T elevation in acute ischemic stroke. BMC Neurol 14:96
Faiz KW, Thommessen B, Einvik G, Omland T, Ronning OM (2014b) Prognostic value of high-sensitivity cardiac troponin T in acute ischemic stroke. J Stroke Cereb Dis Off J Natl Stroke Assoc 23:241–248
Filipczyk AA, Passier R, Rochat A, Mummery CL (2007) Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling. Cell Mol Life Sci CMLS 64:704–718
Fonarow GC, Pan W, Saver JL et al (2012) Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA 308:257–264
Harlan SM, Reiter RS, Sigmund CD, Lin JL, Lin JJ (2008) Requirement of TCTG(G/C) direct repeats and overlapping GATA site for maintaining the cardiac-specific expression of cardiac troponin T in developing and adult mice. Anat Rec 291:1574–1586
Hijazi Z, Siegbahn A, Andersson U et al (2014) High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Circulation 129:625–634
Kerr G, Ray G, Wu O, Stott DJ, Langhorne P (2009) Elevated troponin after stroke: a systematic review. Cerebrovasc Dis 28:220–226
Lyckman AW, Horng S, Leamey CA et al (2008) Gene expression patterns in visual cortex during the critical period: synaptic stabilization and reversal by visual deprivation. Proc Natl Acad Sci U S A 105:9409–9414
Masuda T, Sato K, Yamamoto S et al (2002) Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke J Cereb Circ 33:1671–1676
Oluleye OW, Folsom AR, Nambi V, Lutsey PL, Ballantyne CM, Investigators AS (2013) Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality. Ann Epidemiol 23:66–73
Reeves MJ, Fonarow GC, Smith EE et al (2012) Representativeness of the get with the guidelines-stroke registry: comparison of patient and hospital characteristics among Medicare beneficiaries hospitalized with ischemic stroke. Stroke J Cereb Circ 43:44–49
Song HS, Back JH, Jin DK et al (2008) Cardiac troponin T elevation after stroke: relationships between elevated serum troponin T, stroke location, and prognosis. J Clin Neurol 4:75–83
Whiteley W, Chong WL, Sengupta A, Sandercock P (2009) Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke J Cereb Circ 40:e380–e389
Sources of Funding
This study was supported by the Peritz and Chantal Scheinberg Cerebrovascular Research Fund and by the Sol Irwin Juni Trust Fund.
Conflict of Interest
All authors have nothing to disclose
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maoz, A., Rosenberg, S. & Leker, R.R. Increased High-Sensitivity Troponin-T Levels Are Associated with Mortality After Ischemic Stroke. J Mol Neurosci 57, 160–165 (2015). https://doi.org/10.1007/s12031-015-0593-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-015-0593-7